Supply of Trastuzumab Deruxtecan Concentrate Solution for Infusion

This tender, reference number RC/26-27/154, is issued by the DDG (Prov), O/o DGAFMS, Ministry of Defence, New Delhi, for the supply of PVMS No 011094, specifically Inj Trastuzumab Deruxtecan concentrate solution for infusion 100 mg/vial. The IHQ of MoD (Army)-(OSCC) is the originating organization. The tender is for Goods, categorized under Drugs and Pharmaceutical Products, and falls under a Buy form of contract. Bidders must adhere to a two-cover system, with Cover 1 encompassing Fee/PreQual/Technical documents, and Cover 2 dedicated to the financial bid (BoQ). Key dates for participation include document download from 23rd October 2026, 06:00 PM, to 13th November 2026, 10:00 AM, with bid submissions also commencing on 30th October 2026, 06:00 PM, and concluding on 13th November 2026, 10:00 AM. The bid opening is scheduled for 13th November 2026, 11:00 AM, at the DP portal and the A Block Reception, O/o DGAFMS. A significant Earnest Money Deposit (EMD) of ₹1,05,07,000 is required, payable to "The President of India through office of DGAFMS" at New Delhi, with EMD through Bank Guarantee/Standby Letter of Credit or EMD exemption being permissible. The period of work is stipulated as 45 days, with a bid validity of 120 days. Interested parties are advised to refer to the NIT document and the comprehensive RFP for detailed technical and eligibility criteria.